National Cancer Institute Grant: Accelerating Cancer Diagnosis Technologies

The National Cancer Institute is offering a grant to academic and industrial research partnerships for accelerating the translation of technologies for cancer diagnosis and treatment. Funding may support the enhancement, validation, and optimization of innovative systems for preclinical or clinical molecular diagnosis or in vitro imaging. This grant emphasizes translational plans to deliver new capabilities for cancer diagnosis not yet widely used in the field. The interdisciplinary, multi-institutional research teams are encouraged to collaborate and implement strategies to solve targeted cancer problems. Clinical trials to test functionality and validate performance are supported, but commercial production or basic research projects are not funded. Closing date for applications is December 21, 2017.

Opportunity ID: 270550

Apply

General Information

Document Type::	Grants Notice
Funding Opportunity Number::	PAR-15-075
Funding Opportunity Title::	Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment (R01)
Opportunity Category::	Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity::	Education
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s)::	93.394 — Cancer Detection and Diagnosis Research
Cost Sharing or Matching Requirement::	No
Version::	Synopsis 3
Posted Date::	Dec 16, 2014
Last Updated Date::	Dec 21, 2017
Original Closing Date for Applications::	Jan 07, 2017
Current Closing Date for Applications::	Dec 21, 2017
Archive Date::	Jan 20, 2018
Estimated Total Program Funding::
Award Ceiling::	$
Award Floor::	$

Eligibility

Eligible Applicants::

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Additional Information on Eligibility::

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name::	National Institutes of Health
Description::	This Funding Opportunity Announcement (FOA) encourages applications from research partnerships formed by academic and industrial investigators, to accelerate the translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging that are designed to solve a targeted cancer problem. The proposed systems may include molecular diagnosis, molecular imaging or related research resources. Funding may be requested to enhance, adapt, optimize, validate, and otherwise translate the following examples, among others: (a) current commercially supported systems, (b) next-generation systems, (c) quality assurance and quality control, (d) validation and correlation studies, (e) quantitative imaging, and (f) related research resources. Because applications should be translational in scope, this FOA defines innovation as a coherent translational plan to deliver emerging or new capabilities for preclinical or clinical use that are not yet broadly employed in preclinical or clinical settings. In addition, innovation may be considered as delivery of a new capability to end users. The partnership on each application should establish an inter-disciplinary, multi-institutional research team to work in strategic alliance to implement a coherent strategy to develop and translate their system to solve their chosen cancer problem. This FOA will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work. This FOA does not intend to support either actual commercial production or basic research projects that do not emphasize translation.
Link to Additional Information::
Grantor Contact Information::	If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version	Modification Description	Updated Date
Synopsis 3	Expired and Re-issued as PAR-18-530	Dec 21, 2017
Synopsis 2	Modified the close date field, in accordance with NOT-CA-16-030.	Mar 03, 2016
Synopsis 1

Package Status

Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:

Package No: 1

Assistance Listings:
Competition ID:	FORMS-C
Competition Title:	FORMS-C
Opportunity Package ID:	PKG00210823
Opening Date:	Feb 06, 2015
Closing Date:	Mar 31, 2016
Agency Contact Information::	eRA Commons Help Desk Monday to Friday 7 am to 8 pm ET http://grants.nih.gov/support/
Who Can Apply::	Organization Applicants
mendatory_forms	SF424 (R & R) [V2.0] PHS 398 Research Plan [V2.0] PHS 398 Cover Page Supplement [V2.0] Research and Related Senior/Key Person Profile (Expanded) [V2.0] Research And Related Other Project Information [V1.3] Project/Performance Site Location(s) [V2.0]
optional_forms	R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.3] Planned Enrollment Report [V1.0] PHS 398 Cumulative Inclusion Enrollment Report [V1.0] PHS 398 Modular Budget [V1.2] Research & Related Budget [V1.3]

Package No: 2